Haga Hospital — Clinical Trial Site

129 Registered trials

56 Currently recruiting

Organisation

Haga Hospital

Location

's-Gravenhage, Netherlands

Identifier

ORG-100028319

Address

Leyweg 275, 2545 CH, Netherlands

Departments

-
#2900:Internal Medicine
#3710: Cardiology
031007: Internal Medicine
2501: Hematology
2602: Cardiology
3710: Cardiology
Cardiologie
Cardiology
Cardiology Department
CardioResearch
Department of Hematology
Department of Medical Oncology
Department of Oncology
Department Pulmonology
Dept Internal Medicine
gastroenterology
Gynaecology
Haga Ziekenhuis (#1)
Hagaziekenhuis – Interne geneeskunde
Hematologie
Hematology
ICU
Intensive care
Internal Medicine
Internal Medicine - Hematology
Internal Medicine - Oncology
Internal Medicine / Oncology
Interne Geneeskunde
Interne Geneeskunde/oncologie
Interne/Oncologie
Juliana Kinderziekenhuis
Kindergeneeskunde
Longziekten
Mammapoli/Oncologie
Medical Oncology
Medische Oncologie
N/A
Nephrology
Neurology
NL10009: Hematology
Oncology
Oncology department
Ophthalmology
Otorhinolaryngology
Pulmonology
Pulmonology Department
Radiotherapy
Rheumatology
Surgery
Vascular Medicine

Clinical trials at this site (129)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
Avelumab Short Maintenance Trial Pending

2024-512975-11-01 urothelial cancer 11
Ultrasound-guided Radiofrequency Ablation versus radioactive Iodine as treatment for Hyperthyroidism caused by Solitary Autonomous Thyroid N… Pending

2024-515602-34-01 Hyperactive thyroid nodules 11
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
A phase III trial of a De-escalated Immune-strategy During first-line treAtment in patients with metastatic non-small Cell lung cancer (NSCL… Pending

2025-520792-67-00 Patients with advanced, metastatic NSCLC that have not 5
A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o… Pending

2025-523117-28-00 Relapsed or Refractory Multiple Myeloma 4
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending

2025-523400-72-00 Cystic fibrosis 4
Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an… Pending

2025-524229-41-00 Triple negative breast cancer 5
A Phase 3 Study Comparing JNJ-79635322 and an anti-BCMAxCD3 Bispecific Antibody in Participants with Relapsed or Refractory Multiple Myeloma Recruiting

2025-522007-18-00 Relapsed or Refractory Multiple Myeloma 5 2026-05-27
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB 3111) Compared With Venetoclax Plus Acalabrutinib in Patients With Pre… Recruiting

2025-524366-21-00 treatment-naive Chronic Lymphocytic Leukemia 5 2026-04-29
ROSETTA Breast-01: The effects and safety of pumitamig in patients with triple-negative breast cancer Recruiting

2025-521884-12-00 First line triple-negative breast cancer (TNBC) 5 2026-03-19
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 Newly Diagnosed Multiple Myeloma 4 2026-01-08
ASPIRING Recruiting

2024-516188-10-00 Intracerebral haemorrhage 6 2025-10-07
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
The QUEEN-IVF trial: Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation: An open-label, randomized crossover pi… Recruiting

2024-511190-30-00 Short-coupled Idiopathic Ventricular Fibrillation 4 2024-11-25
Disitamab Vedotin with Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Recruiting

2022-501105-12-00 Urothelial Carcinoma 5 2024-07-15
Long-term Extension Study to Assess Adverse Events and Tolerability of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Ag… Recruiting

2022-501099-24-00 Migraine 5 2023-12-22
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) … Recruiting

2022-501100-94-00 Episodic Migraine 5 2023-11-08
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participan… Recruiting

2023-505749-14-00 c-Met overexpressing EGFR wildtype non-squamous non-sma 5 2022-03-20